Effaclar Adapalene 1 mg/g Gel
by LOreal USA Products Inc · 1 TUBE in 1 CARTON (49967-591-01) / 45 g in 1 TUBE
NDC 49967-0591-01
🏷️ FDA NDC (as labeled)
49967-591-01
billing pads the product segment with a zero
This package
Contains45 g in 1 tube
Pack sizes2 compare ↓
Also comes in:
3 g 49967-0591-02
OTC
Generic
On market
Non-controlled
🗂️ Data synced Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
🆔 Identity & classification
FDA NDC (as labeled)
49967-591-01
Product NDC
49967-591
11-digit billing NDC
49967059101
RxCUI
307731
UNII
1L4806J2QF
UPC
3606000527553
Application #
ANDA091314
SPL Set ID
a47b204a-3815-4a2b-9a7d-2c2b65b837bb
Established class (EPC)
Retinoid
Chemical class
Retinoids
DEA schedule
Non-controlled
Marketing category
ANDA
Marketing status
On market
FDA listing status
Listed (active directory)
Marketing start
2019-08-23
Route
TOPICAL
Dosage form
GEL
Substance
ADAPALENE
Why two NDCs?
The FDA registers this code as 49967-591-01 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 49967-0591-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.
🏷️ RxNorm drug class
This medicine belongs to the Retinoid class.
Pharmacologic class
Retinoid
Drug family (ATC)
Retinoids for topical use in acne
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.
🏭 Manufacturer & labeler
LabelerLOreal USA Products Inc
Application holderGLENMARK PHARMACEUTICALS INC USA
FDA applicationANDA091314 (ANDA)
Labeler code49967
First marketedAug 2019
Product typeHuman Otc Drug
Portfolio44 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.
🩺 Clinical
📗 Our plain-language guide HelloPharmacist
- Most people start to see meaningful improvement after 8 to 12 weeks of consistent use. In the early weeks, your acne might actually look a little worse before it gets better — this...
- How long does it take for adapalene to clear up my acne?
- Yes, redness, dryness, flaking, and mild stinging are the most common side effects, especially in the first few weeks. They're usually mild to moderate and tend to get better as yo...
- My skin is really red and dry after starting adapalene — is that normal?
Patient education
Supplement & herbal interactions
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.
💬 Questions about Adapalene?
Ask a pharmacist →
Ask a licensed pharmacist directly — free, answered by our team.
🧪 Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured
IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.
💲 Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per g | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size:
3 g
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.
🔁 Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Adapalene 1 mg/g 00536-1412-20 | RUGBY | 1 tube | $0.467 | — | Availability likely | — |
| Adapalene 1 mg/g 46122-0768-36 | AMERISOURCE | 1 tube | $0.467 | — | Availability likely | — |
| Adapalene 1 mg/g 51672-2150-01 | Sun | 1 tube | $0.467 | — | Availability likely | — |
| Adapalene 1 mg/g 70000-0666-01 | Cardinal | 1 tube | $0.467 | — | Availability likely | — |
| Adapalene 1 mg/g 00168-0424-46 | E. | 1 tube | $2.490 | AB | Availability likely | — |
| Differin 1 mg/g 00299-4910-00 | Galderma | 1 tube | — | — | FDA listed | — |
| PanOxyl 1 mg/g 00316-0143-15 | CROWN | 1 tube | — | — | FDA listed | — |
| PanOxyl 1 mg/g 00316-0284-15 | CROWN | 1 tube | — | — | FDA listed | — |
| Adapalene 1 mg/g 00363-0888-05 | Walgreens | 1 tube | — | — | FDA listed | — |
| Adapalene 1 mg/g 00363-1401-05 | Walgreens | 1 tube | — | — | FDA listed | — |
| Adapalene 1 mg/g 00363-4110-05 | Walgreens | 1 tube | — | — | FDA listed | — |
| Proactiv MD Adapalene Acne Treatment .1 g/100g 11410-0958-15 | Alchemee, | 1 tube | — | — | FDA listed | — |
| Adapalene 1 mg/g 11822-0062-01 | RITE | 1 tube | — | — | FDA listed | — |
| Adapalene 1 mg/g 21130-0754-05 | Safeway, | 1 tube | — | — | FDA listed | — |
| Adapalene 1 mg/g 30142-0725-05 | The | 1 tube | — | — | FDA listed | — |
| Adapalene 1 mg/g 36800-0088-05 | TOP | 1 tube | — | — | FDA listed | — |
| Adapalene 1 mg/g 41250-0288-05 | MEIJER, | 1 tube | — | — | FDA listed | — |
| Adapalene 1 mg/g 49967-0354-01 | LOreal | 1 tube | — | — | FDA listed | — |
| Effaclar 1 mg/gthis 49967-0591-01 | LOreal | 1 tube | — | — | FDA listed | — |
| Effaclar 1 mg/g 49967-0592-01 | LOreal | 1 tube | — | — | FDA listed | — |
| Adapalene 1 mg/g 51316-0114-05 | CVS | 1 tube | — | — | FDA listed | — |
| Adapalene 1 mg/g 55910-0880-05 | Dolgencorp, | 1 tube | — | — | FDA listed | — |
| Adapalene 1 mg/g 59726-0114-05 | P | 1 tube | — | — | FDA listed | — |
| Adapalene 1 mg/g 59726-0888-05 | P | 1 tube | — | — | FDA listed | — |
| Adapalene 1 mg/g 69842-0088-05 | CVS | 1 tube | — | — | FDA listed | — |
| Neutrogena Adapalene 0.1% Acne Treatment 1 mg/g 69968-0826-01 | Kenvue | 1 tube | — | — | FDA listed | — |
| Neutrogena Evenly Clear Retinoid Adapalene Gel 0.1% Acne Treatment 1 mg/g 69968-0945-02 | Kenvue | 1 tube | — | — | FDA listed | — |
| Neutrogena Evenly Clear Retinoid Adapalene Gel 0.1% Acne Treatment 1 mg/g 69968-1004-02 | Kenvue | 1 tube | — | — | FDA listed | — |
| Curist Acne Relief .1 g/100g 72559-0015-13 | Little | 1 tube | — | — | FDA listed | — |
| Adapalene 1 mg/g 72657-0158-15 | GLENMARK | 1 bottle | — | — | FDA listed | — |
| Adapalene 1 mg/g 73581-0019-06 | YYBA | 1 tube | — | — | FDA listed | — |
| Adapalene 1 mg/g 73581-0214-06 | YYBA | 1 tube | — | — | FDA listed | — |
| Adapalene 1 mg/g 73581-0215-45 | YYBA | 1 tube | — | — | FDA listed | — |
| Adapalene 1 mg/g 73581-0216-45 | YYBA | 1 tube | — | — | FDA listed | — |
| Adapalene Gel 0.1% .1 g/100g 73715-0003-01 | MOHNARK | 30 g | — | — | Discontinued | — |
| Adapalene 1 mg/g 76162-0114-05 | Topco | 1 tube | — | — | FDA listed | — |
| Adapalene 1 mg/g 79481-1140-05 | Meijer | 1 tube | — | — | FDA listed | — |
| Adapalene 1 mg/g 79903-0338-05 | Wal-Mart | 1 tube | — | — | FDA listed | — |
| Adapalene 1 mg/g 82442-0105-01 | Target | 1 tube | — | — | FDA listed | — |
| Adapalene 1 mg/g 72162-1048-02 | Bryant | 1 tube | — | AB | FDA listed | — |
| Adapalene 1 mg/g 63629-8791-01 | Bryant | 1 tube | — | AB | FDA listed | — |
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.
⏳ Availability & generic status
🏛️
2019
On the market since
Aug 2019
📍
2026
Currently FDA-listed
7 years listed
🔓
·
Generic on the market
this product is a generic
✅This is a generic drug
This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.
Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.
📊 Medicare Part D spend CMS · PART D · 2026 (Q1)
Medicare Part D (outpatient prescription) spending for Adapalene (matched by generic name) — the program that covers self-administered drugs. 8 manufacturers.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Adapalene. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$999.6K
Claims incl. refills
2.4K
Beneficiaries
1.8K
Spend / beneficiary
$553.81
Spend / claim
$410.69
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.
🔬 Reported adverse events (FAERS)
Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Effaclar (this brand).
Top reported reactions
Age at onset
Reporter sex
Male · 33%
Female · 67%
Unknown · 0%
Serious outcomes
Reports over time (by year) — tap or hover for the count & year
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
📦 Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Status |
|---|---|---|---|
| 49967-0591-01 You're viewing this | 1 TUBE in 1 CARTON (49967-591-01) / 45 g in 1 TUBE | 2019-08-23 | Active |
| 49967-0591-02 | 1 TUBE in 1 CARTON (49967-591-02) / 3 g in 1 TUBE | 2019-10-22 | Active |
Pack size FAQ
What quantity is in NDC 49967-0591-01?
NDC 49967-0591-01 is listed by the FDA — 1 tube in 1 carton / 45 g in 1 tube.
What NDC number is used to bill for this package of Effaclar Adapalene 1 mg/g Gel?
Bill NDC 49967-0591-01 — the 11-digit billing format is 49967059101. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.
🧭 About this NDC listing & data coverage
Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | ✓ Available |
| Inactive ingredients (structured) | — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available. |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.
Questions about this listing
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 49967-591-01, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 49967-0591-01, written without dashes as 49967059101. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 49967-0591-01, the first segment (49967) is the labeler code FDA assigned to LOreal USA Products Inc; the middle segment (0591) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (01) identifies this exact package size and type. Together they name one specific package of one specific product.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by LOreal USA Products Inc. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 1 other package presentation of this same product, including 1 tube (49967-0591-02). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
LOreal USA Products Inc is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
📄 FDA label — Drug Facts FDA SPL
The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage
⏱️ Dosage and Administration
⚠️ Warnings
🧪 Active Ingredient
🧪 Inactive Ingredients
🎯 Purpose
🎯 Indications and Usage ▾
Use • for the treatment of acne
⏱️ Dosage and Administration ▾
Directions Adults and children 12 years of age and older: • use once daily • clean the skin gently and pat dry before applying the product • cover the entire affected area with a thin layer. For example, if your acne is on the face, apply the product to the entire face. • do not use more than one time a day. Applying more than directed will not provide faster or better results, but may worsen skin irritation. Children under 12 years of age : ask a doctor
⚠️ Warnings ▾
Warnings For external use only Do not use • on damaged skin (cuts, abrasions, eczema, sunburn) • if you are allergic to adapalene or any of the ingredients in this product. If pregnant or breast-feeding , ask a doctor before use. When using this product • limit sun exposure, including light from tanning beds, and use sunscreen when going outdoors • do not wax to remove hair in areas where the product has been applied • during the early weeks of use, your acne may appear to worsen before it improves (this is normal); continue using as directed, unless you get irritation that becomes severe • irritation (redness, itching, dryness, burning) is more likely to occur: • in the first few weeks of use • if using more than one topical acne medication at a time • but irritation usually lessens with continued use of this product • it may take up to 3 months of once daily use to see results • avoid product contact with eyes, lips, and mouth.
If contact occurs, immediately flush the area with water. • wash hands after use Stop use and ask doctor if • you become pregnant, or are planning to become pregnant, while using the product • you have symptoms of an allergic reaction (such as itching, rash, hives, swelling of the lips, eyelids, and shortness of breath) • irritation becomes severe • you see no improvement after 3 months of once daily use
🧪 Active Ingredient ▾
Active ingredient Adapalene USP 0.1% (retinoid)* *read consumer information leaflet
🧪 Inactive Ingredients ▾
Inactive Ingredients carbomer homopolymer, edetate disodium, methylparaben, poloxamer 182, propylene glycol, purified water, and sodium hydroxide
🎯 Purpose ▾
Purpose Acne treatment
No label section mentions that — try another word, or open the full label on DailyMed below.
Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA.
Prefer the government’s original formatting? View this label on DailyMed ↗
For educational and professional reference only — not medical advice. Pricing reflects published
NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.